Author

Marijke Wasielewski

Observed name: Wasielewski, M (Marijke)

Observed institutions: University Medical Center Groningen, University of Groningen, Erasmus MC, Cancer Genomics Centre, Erasmus University Rotterdam

OpenAlex ID: A5110213951

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

2002 · Hanne Meijers-Heijboer, Ans van den Ouweland, et al. · Nature Genetics · 1,131

BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants

2006 · Fons Elstrodt, Antoinette Hollestelle, et al. · Cancer Research · 309

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

2009 · Antoinette Hollestelle, Jord H. A. Nagel, et al. · Breast Cancer Research and Treatment · 308

The CHEK2 1100delC Mutation Identifies Families with a Hereditary Breast and Colorectal Cancer Phenotype

2003 · Hanne Meijers-Heijboer, Marijke Wasielewski, et al. · The American Journal of Human Genetics · 226

PDF

Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer Susceptibility

2003 · Mieke Schutte, Sheila Seal, et al. · The American Journal of Human Genetics · 136

PDF

Discovering moderate-risk breast cancer susceptibility genes

2010 · Antoinette Hollestelle, Marijke Wasielewski, et al. · Current Opinion in Genetics & Development · 109

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines

2006 · Marijke Wasielewski, Fons Elstrodt, et al. · Breast Cancer Research and Treatment · 108

A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers

2006 · Deborah Thompson, Sheila Seal, et al. · Cancer Epidemiology Biomarkers & Prevention · 61

PDF

CHEK2 1100delC and male breast cancer in the Netherlands

2008 · Marijke Wasielewski, Michael A. den Bakker, et al. · Breast Cancer Research and Treatment · 57

Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls

2009 · Olivia Fletcher, Nichola Johnson, et al. · Cancer Epidemiology Biomarkers & Prevention · 55

PDF

MUTYH gene variants and breast cancer in a Dutch case–control study

2012 · Astrid A. Out, Marijke Wasielewski, et al. · Breast Cancer Research and Treatment · 52

PDF

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer

2010 · Marijke Wasielewski, Astrid A. Out, et al. · Breast Cancer Research and Treatment · 52

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy

2014 · Marijke Wasielewski, Karin Y van Spaendonck-Zwarts, et al. · Open Heart · 51

PDF

Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?

2004 · Csilla I. Szabo, Mieke Schutte, et al. · Cancer Research · 50

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling

2006 · Marijke Wasielewski, Jord H. A. Nagel, et al. · Breast Cancer Research and Treatment · 40

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes

2011 · Jord H. A. Nagel, Justine K. Peeters, et al. · Breast Cancer Research and Treatment · 39

CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal Cancer

2008 · Marijke Wasielewski, Hans Vasen, et al. · Clinical Cancer Research · 35

Association of rare MSH6 variants with familial breast cancer

2009 · Marijke Wasielewski, Muhammad Riaz, et al. · Breast Cancer Research and Treatment · 21

Exon Expression Arrays as a Tool to Identify New Cancer Genes

2008 · Mieke Schutte, Fons Elstrodt, et al. · PLoS ONE · 15

PDF

Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines

2008 · Marijke Wasielewski, Pejman Hanifi-Moghaddam, et al. · Breast Cancer Research and Treatment · 11

Supplementary Figure S2 from BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants